臨床試験を検索：Shanchol™: 二価 (O1 および O139) 全細胞を死滅させた経口コレラワクチン
合計16件
-
International Vaccine InstituteChristian Medical College, Vellore, India; Shantha Biotechnics Limited完了
-
Sanofi Pasteur, a Sanofi Company完了
-
International Vaccine InstituteShantha Biotechnics Limited; Armauer Hansen Research Institute, Ethiopia; Ministry of Health,...完了
-
Sachin DesaiIndian Council of Medical Research; National Institute of Cholera and Enteric Diseases, India完了
-
Johns Hopkins Bloomberg School of Public HealthBill and Melinda Gates Foundation; Meilleur Accès aux Soins de Santé (M.A. Santé)完了
-
International Vaccine InstituteIndian Council of Medical Research; Institute of Child Health; National Institute of Cholera and... と他の協力者わからない
-
International Vaccine InstituteNational Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics Limited完了
-
Jiangsu Province Centers for Disease Control and...完了経口O1 / O139コレラワクチン（腸溶性カプセル）の安全性
-
International Vaccine InstituteNational Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics Limited完了
-
International Vaccine InstituteIndian Council of Medical Research; National Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics Limited完了
-
International Vaccine InstituteEuBiologics Co.,Ltd完了
-
International Vaccine InstituteIndian Council of Medical Research; National Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics Limited完了
-
International Centre for Diarrhoeal Disease Research...Göteborg University; Kyoto University完了
-
Sanofi Pasteur, a Sanofi Company完了百日咳の予防接種 | ジフテリアの予防接種 | 破傷風の予防接種 | 肺炎球菌の予防接種 | B型肝炎の予防接種 | ポリオ予防接種 | ヘモフィルス インフルエンザ B 型の予防接種 | ロタウイルスの予防接種タイ
-
GlaxoSmithKline完了